Title:
低分子ＲＮＡ断片の製剤の使用並びに低分子ＲＮＡ断片の製剤及び少なくとも１つの抗癌成分の使用
Document Type and Number:
Japanese Patent JP5745767
Kind Code:
B2
Abstract:
This invention provides therapeutic treatments that prevent or ameliorate thrombocytopenia based on administration of small RNA fragments. More specifically, this invention provides an improved chemotherapeutic regimen that prevents or ameliorates bone marrow suppression and thrombocytopenia induced by anti-cancer drugs, wherein the chemotherapeutic regimen incorporates administration of small RNA fragments. Further, the present invention provides a therapeutic treatment for thrombocytopenia associated with immune disorders known as Immune Thrombocytopenic Purpura based on administration of small RNA fragments.
Inventors:
Berdyanski, Silvier
John Hull
John Hull
Application Number:
JP2009534661A
Publication Date:
July 08, 2015
Filing Date:
October 26, 2007
Export Citation:
Assignee:
MOLECULAR INTERNATIONAL RESEARCH,INC.
International Classes:
A61K45/00; A61K31/7105; A61K48/00; A61P7/00; A61P35/00; A61P37/04
Domestic Patent References:
| JP52148613A | ||||
| JP63119495A |
Other References:
cancer treatment reports,1983年,vol.67, no.7-8,p.611-619
Attorney, Agent or Firm:
Tadao Hirata